back to top

AbbVie This autumn 2024 adjusted earnings decline regardless of 6% income development | AlphaStreet

Related Article

Biopharmaceutical firm AbbVie, Inc. (NYSE: ABBV) introduced fourth-quarter 2024 monetary outcomes, reporting a double-digit dip in adjusted earnings and a rise in revenues.

The corporate reported worldwide internet revenues of $15.1 billion for the December quarter, up 6% from the corresponding interval of 2023. The principle working segments registered development.

Web earnings, adjusted for particular gadgets, declined to $2.16 per share in This autumn from $2.79 per share within the year-ago quarter. On a reported foundation, it was a internet lack of $22 million or $0.02 per share within the fourth quarter, in comparison with a revenue of $822 million or $0.46 per share final 12 months.

Prior Efficiency

Related Article